Cargando…

Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review

Most previous treatment guidelines for pregnant women with mechanical heart valves recommend that low molecular weight heparin (LMWH) should be applied once every 12 hours and only as required to reach peak anti-Xa levels of approximately 1.0 to 1.2 IU/mL, but it is commonly associated with subthera...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Chunqiang, Wu, Haiying, Wu, Wenying, Feng, Peiming, Nie, Minghui, Zhao, Li, Meng, Fanyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803450/
https://www.ncbi.nlm.nih.gov/pubmed/36596070
http://dx.doi.org/10.1097/MD.0000000000032550
_version_ 1784861888554729472
author Bai, Chunqiang
Wu, Haiying
Wu, Wenying
Feng, Peiming
Nie, Minghui
Zhao, Li
Meng, Fanyue
author_facet Bai, Chunqiang
Wu, Haiying
Wu, Wenying
Feng, Peiming
Nie, Minghui
Zhao, Li
Meng, Fanyue
author_sort Bai, Chunqiang
collection PubMed
description Most previous treatment guidelines for pregnant women with mechanical heart valves recommend that low molecular weight heparin (LMWH) should be applied once every 12 hours and only as required to reach peak anti-Xa levels of approximately 1.0 to 1.2 IU/mL, but it is commonly associated with subtherapeutic trough levels, consequently with an inadequate level of anticoagulation. Our case report here together with a literature review suggests that dose-adjusted (Target trough anti-Xa levels of 0.6 to 0.7 IU/mL and with peak anti-Xa levels of around 1.0 to 1.2 IU/mL or < 1.5 IU/mL) LMWH should be given thrice daily throughout pregnancy. In addition, the findings of this rare case indicate that a combination of LMWH and warfarin is effective in the treatment of small thromboses in pregnancy. PATIENT CONCERNS: In the 1(st) trimester of pregnancy, a 28-year old pregnant female with a mechanical valve had a significant increase in the aortic valve flow rate and suspected mechanical valve thrombosis. DIAGNOSES: The peak velocity of the pregnant female aortic mechanical valve increased, and mechanical valve thrombosis was suspected. INTERVENTIONS: We adjusted the enoxaparin sodium dose every 12 hours to 1 injection every 8 hours, with a total daily dose of 160 mL. Based on the original application of LMWH, warfarin (3 mg/day) was recommended. OUTCOMES: The pregnant woman delivered a live baby by cesarean section, and the peak flow velocity of the mechanical valve in the aortic position was reduced to nearly equivalent to the patient’s pre-pregnancy status. The mother and the baby were in good health at the time of discharge. LESSONS: LMWH is administered twice daily, and anti-Xa trough levels are mostly in a subtherapeutic state, which may lead to insufficient anticoagulation and thrombosis. Dose-adjusted LMWH thrice daily throughout pregnancy is the recommended treatment for pregnant women with mechanical heart valves. The combination of LMWH and warfarin exhibited good efficacy for the treatment of small thromboses.
format Online
Article
Text
id pubmed-9803450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-98034502023-01-03 Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review Bai, Chunqiang Wu, Haiying Wu, Wenying Feng, Peiming Nie, Minghui Zhao, Li Meng, Fanyue Medicine (Baltimore) 5600 Most previous treatment guidelines for pregnant women with mechanical heart valves recommend that low molecular weight heparin (LMWH) should be applied once every 12 hours and only as required to reach peak anti-Xa levels of approximately 1.0 to 1.2 IU/mL, but it is commonly associated with subtherapeutic trough levels, consequently with an inadequate level of anticoagulation. Our case report here together with a literature review suggests that dose-adjusted (Target trough anti-Xa levels of 0.6 to 0.7 IU/mL and with peak anti-Xa levels of around 1.0 to 1.2 IU/mL or < 1.5 IU/mL) LMWH should be given thrice daily throughout pregnancy. In addition, the findings of this rare case indicate that a combination of LMWH and warfarin is effective in the treatment of small thromboses in pregnancy. PATIENT CONCERNS: In the 1(st) trimester of pregnancy, a 28-year old pregnant female with a mechanical valve had a significant increase in the aortic valve flow rate and suspected mechanical valve thrombosis. DIAGNOSES: The peak velocity of the pregnant female aortic mechanical valve increased, and mechanical valve thrombosis was suspected. INTERVENTIONS: We adjusted the enoxaparin sodium dose every 12 hours to 1 injection every 8 hours, with a total daily dose of 160 mL. Based on the original application of LMWH, warfarin (3 mg/day) was recommended. OUTCOMES: The pregnant woman delivered a live baby by cesarean section, and the peak flow velocity of the mechanical valve in the aortic position was reduced to nearly equivalent to the patient’s pre-pregnancy status. The mother and the baby were in good health at the time of discharge. LESSONS: LMWH is administered twice daily, and anti-Xa trough levels are mostly in a subtherapeutic state, which may lead to insufficient anticoagulation and thrombosis. Dose-adjusted LMWH thrice daily throughout pregnancy is the recommended treatment for pregnant women with mechanical heart valves. The combination of LMWH and warfarin exhibited good efficacy for the treatment of small thromboses. Lippincott Williams & Wilkins 2022-12-30 /pmc/articles/PMC9803450/ /pubmed/36596070 http://dx.doi.org/10.1097/MD.0000000000032550 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 5600
Bai, Chunqiang
Wu, Haiying
Wu, Wenying
Feng, Peiming
Nie, Minghui
Zhao, Li
Meng, Fanyue
Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review
title Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review
title_full Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review
title_fullStr Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review
title_full_unstemmed Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review
title_short Anticoagulation for mechanical heart valves during pregnancy: A case report and a literature review
title_sort anticoagulation for mechanical heart valves during pregnancy: a case report and a literature review
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803450/
https://www.ncbi.nlm.nih.gov/pubmed/36596070
http://dx.doi.org/10.1097/MD.0000000000032550
work_keys_str_mv AT baichunqiang anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview
AT wuhaiying anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview
AT wuwenying anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview
AT fengpeiming anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview
AT nieminghui anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview
AT zhaoli anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview
AT mengfanyue anticoagulationformechanicalheartvalvesduringpregnancyacasereportandaliteraturereview